JPM UK Equity Growth Fund C2 - Net AccumulationRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 11.6 | 12.2 | |
+/-Cat | - | - | - | 3.6 | 5.5 | |
+/-B’mrk | - | - | - | 4.0 | 4.0 | |
Category: UK Flex-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 21/11/2024 | GBP 1.26 | |
Day Change | -0.08% | |
Morningstar Category™ | UK Flex-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00BN0X7206 | |
Fund Size (Mil) 21/11/2024 | GBP 152.66 | |
Share Class Size (Mil) 21/11/2024 | GBP 1.31 | |
Max Initial Charge | - | |
Ongoing Charge 01/01/2024 | 0.70% |
Investment Objective: JPM UK Equity Growth Fund C2 - Net Accumulation |
To provide capital growth over the long-term (5-10 years) by investing at least 80% of the Fund's assets in a growth style biased portfolio of UK companies. At least 80% of assets invested in a growth style biased portfolio of equities of companies that are domiciled, or carrying out the main part of their economic activity, in the UK. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Guy Anderson 31/05/2021 | ||
Manasij Hajra 01/02/2023 | ||
Inception Date 06/05/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE All Share NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM UK Equity Growth Fund C2 - Net Accumulation | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 5.68 |
Unilever PLC | Consumer Defensive | 5.54 |
Shell PLC | Energy | 5.06 |
3i Group Ord | 4.30 | |
HSBC Holdings PLC | Financial Services | 3.66 |
Increase Decrease New since last portfolio | ||
JPM UK Equity Growth Fund C2 - Net Accumulation |